News Releases Year: - Any -202020192018201720162015201420132012 Items per page 102550 03/11/20 Summary ToggleClearside Biomedical Appoints Dr. George Lasezkay as President and Chief Executive Officer PDF Version 03/11/20 Summary ToggleClearside Biomedical Announces License Agreement with Arctic Vision for XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension) in Greater China and South Korea PDF Version 02/27/20 Summary ToggleClearside Biomedical to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update on Wednesday, March 11, 2020 PDF Version 02/26/20 Summary ToggleClearside Biomedical to Present at Two Upcoming Investor Conferences in March 2020 PDF Version 02/25/20 Summary ToggleClearside Biomedical Pipeline Highlighted in Oral Presentations at the Annual Angiogenesis and Macula Society Meetings PDF Version 02/05/20 Summary ToggleClearside Biomedical Announces Presentations to be Given at Angiogenesis and Macula Society Conferences PDF Version 01/28/20 Summary ToggleBausch Health and Clearside Biomedical Announce Publication of PIVOTAL Phase 3 Data ON XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension) in Ophthalmology PDF Version 01/06/20 Summary ToggleClearside Biomedical to Present at the 38th Annual J.P. Morgan Healthcare Conference PDF Version 11/13/19 Summary ToggleClearside Biomedical to Present at the Stifel 2019 Healthcare Conference PDF Version 11/06/19 Summary ToggleClearside Biomedical Announces Third Quarter 2019 Financial Results and Provides Corporate Update PDF Version Pagination First page First Previous page Page 1 Current page 2 Page 3 Page 4 Next page Last page Last
